Ron Bentsur's most recent trade in Nuvectis Pharma Inc was a trade of 150,000 Common Stock done . Disclosure was reported to the exchange on Jan. 6, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Nuvectis Pharma Inc | Ron Bentsur | Director, Chairman & CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 150,000 | 3,675,924 | - | 0 | Common Stock | |
| Nuvectis Pharma Inc | Ron Bentsur | Director, Chairman & CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 5.72 per share. | 05 Nov 2025 | 5,000 | 3,525,924 | - | 5.7 | 28,600 | Common Stock |
| Nuvectis Pharma Inc | Ron Bentsur | Director, Chairman & CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 250,000 | 3,520,924 | - | 0 | Common Stock | |
| Nuvectis Pharma Inc | Ron Bentsur | Director, Chairman & CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 4.65 per share. | 24 Dec 2024 | 4,500 | 3,270,924 | - | 4.7 | 20,925 | Common Stock |
| Beyond Air Inc | Ron Bentsur | Director | 22 Nov 2024 | 45,000 | 45,000 | - | - | Stock Options (Right to buy) | ||
| Beyond Air Inc | Ron Bentsur | Director | 22 Nov 2024 | 45,000 | 0 | - | - | Stock Options (Right to buy) | ||
| Beyond Air Inc | Ron Bentsur | Director | 22 Nov 2024 | 40,000 | 40,000 | - | - | Stock Options (Right to buy) | ||
| Beyond Air Inc | Ron Bentsur | Director | 22 Nov 2024 | 40,000 | 0 | - | - | Stock Options (Right to buy) | ||
| Beyond Air Inc | Ron Bentsur | Director | 22 Nov 2024 | 30,000 | 30,000 | - | - | Stock Options (Right to buy) | ||
| Beyond Air Inc | Ron Bentsur | Director | 22 Nov 2024 | 30,000 | 0 | - | - | Stock Options (Right to buy) | ||
| Beyond Air Inc | Ron Bentsur | Director | 22 Nov 2024 | 25,000 | 25,000 | - | - | Stock Options (Right to buy) | ||
| Beyond Air Inc | Ron Bentsur | Director | 22 Nov 2024 | 25,000 | 0 | - | - | Stock Options (Right to buy) | ||
| Beyond Air Inc | Ron Bentsur | Director | 22 Nov 2024 | 25,000 | 25,000 | - | - | Stock Options (Right to buy) | ||
| Beyond Air Inc | Ron Bentsur | Director | 22 Nov 2024 | 25,000 | 0 | - | - | Stock Options (Right to buy) | ||
| Beyond Air Inc | Ron Bentsur | Director | 22 Nov 2024 | 24,000 | 24,000 | - | - | Stock Options (Right to buy) | ||
| Beyond Air Inc | Ron Bentsur | Director | 22 Nov 2024 | 24,000 | 0 | - | - | Stock Options (Right to buy) | ||
| Nuvectis Pharma Inc | Ron Bentsur | Director, Chairman & CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 4.92 per share. | 15 Nov 2024 | 20,000 | 3,266,424 | - | 4.9 | 98,400 | Common Stock |
| Nuvectis Pharma Inc | Ron Bentsur | Director, Chairman & CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 6.74 per share. | 14 May 2024 | 1,940 | 3,246,424 | - | 6.7 | 13,076 | Common Stock |
| Nuvectis Pharma Inc | Ron Bentsur | Director, Chairman & CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 6.40 per share. | 10 May 2024 | 2,000 | 3,244,484 | - | 6.4 | 12,800 | Common Stock |
| Beyond Air Inc | Ron Bentsur | Director | 20 Mar 2024 | 45,000 | 45,000 | - | - | Stock Option (right to buy) | ||
| Nuvectis Pharma Inc | Ron Bentsur | Director, Chairman & CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 10.29 per share. | 18 Mar 2024 | 5,000 | 3,242,484 | - | 10.3 | 51,450 | Common Stock |
| Nuvectis Pharma Inc | Ron Bentsur | Director, Chairman & CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 11.08 per share. | 10 Oct 2023 | 640 | 3,237,484 | - | 11.1 | 7,091 | Common Stock |
| Nuvectis Pharma Inc | Ron Bentsur | Director, Chairman & CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 11.19 per share. | 06 Oct 2023 | 830 | 3,236,844 | - | 11.2 | 9,288 | Common Stock |
| Nuvectis Pharma Inc | Ron Bentsur | Director, Chairman & CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 11.27 per share. | 06 Oct 2023 | 250 | 3,236,014 | - | 11.3 | 2,818 | Common Stock |
| Nuvectis Pharma Inc | Ron Bentsur | Director, Chairman & CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 10.95 per share. | 04 Oct 2023 | 1,820 | 3,234,364 | - | 11.0 | 19,929 | Common Stock |
| Nuvectis Pharma Inc | Ron Bentsur | Director, Chairman & CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 11.09 per share. | 04 Oct 2023 | 1,400 | 3,235,764 | - | 11.1 | 15,526 | Common Stock |
| Nuvectis Pharma Inc | Ron Bentsur | Director, Chairman & CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 14.34 per share. | 15 Aug 2023 | 235 | 3,232,429 | - | 14.3 | 3,370 | Common Stock |
| Nuvectis Pharma Inc | Ron Bentsur | Director, Chairman & CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 15.15 per share. | 15 Aug 2023 | 115 | 3,232,544 | - | 15.1 | 1,742 | Common Stock |
| Nuvectis Pharma Inc | Ron Bentsur | Director, Chairman & CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 14.66 per share. | 08 Aug 2023 | 180 | 3,232,194 | - | 14.7 | 2,639 | Common Stock |
| Nuvectis Pharma Inc | Ron Bentsur | Director, Chairman & CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 14.83 per share. | 08 Aug 2023 | 120 | 3,232,014 | - | 14.8 | 1,780 | Common Stock |
| Nuvectis Pharma Inc | Ron Bentsur | Director, Chairman & CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 14.85 per share. | 20 Jul 2023 | 225 | 3,231,894 | - | 14.8 | 3,341 | Common Stock |
| Nuvectis Pharma Inc | Ron Bentsur | Director, Chairman & CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 15.06 per share. | 20 Jul 2023 | 110 | 3,231,669 | - | 15.1 | 1,657 | Common Stock |
| Nuvectis Pharma Inc | Ron Bentsur | Director, Chairman & CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 14.33 per share. | 19 Jul 2023 | 200 | 3,231,559 | - | 14.3 | 2,866 | Common Stock |
| Nuvectis Pharma Inc | Ron Bentsur | Director, Chairman & CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 15.03 per share. | 07 Jul 2023 | 150 | 3,231,359 | - | 15.0 | 2,255 | Common Stock |
| Nuvectis Pharma Inc | Ron Bentsur | Director, Chairman & CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 16.19 per share. | 07 Jul 2023 | 110 | 3,231,209 | - | 16.2 | 1,781 | Common Stock |
| Nuvectis Pharma Inc | Ron Bentsur | Director, Chairman & CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 14.88 per share. | 06 Jul 2023 | 320 | 3,231,099 | - | 14.9 | 4,762 | Common Stock |
| Nuvectis Pharma Inc | Ron Bentsur | Director, Chairman & CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 16.50 per share. | 26 Jun 2023 | 750 | 3,230,779 | - | 16.5 | 12,375 | Common Stock |
| Nuvectis Pharma Inc | Ron Bentsur | Director, Chairman & CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 17.88 per share. | 21 Jun 2023 | 500 | 3,230,029 | - | 17.9 | 8,940 | Common Stock |
| Nuvectis Pharma Inc | Ron Bentsur | Director, Chairman & CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 17.41 per share. | 07 Jun 2023 | 230 | 3,229,409 | - | 17.4 | 4,004 | Common Stock |
| Nuvectis Pharma Inc | Ron Bentsur | Director, Chairman & CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 17.53 per share. | 07 Jun 2023 | 120 | 3,229,529 | - | 17.5 | 2,104 | Common Stock |
| Nuvectis Pharma Inc | Ron Bentsur | Director, Chairman & CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 17.28 per share. | 31 May 2023 | 330 | 3,229,179 | - | 17.3 | 5,702 | Common Stock |
| Nuvectis Pharma Inc | Ron Bentsur | Director, Chairman & CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 17.49 per share. | 24 May 2023 | 200 | 3,228,849 | - | 17.5 | 3,498 | Common Stock |
| Nuvectis Pharma Inc | Ron Bentsur | Director, Chairman & CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 17.02 per share. | 16 May 2023 | 320 | 3,228,649 | - | 17.0 | 5,448 | Common Stock |
| Nuvectis Pharma Inc | Ron Bentsur | Director, Chairman & CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 12.13 per share. | 23 Mar 2023 | 230 | 3,228,329 | - | 12.1 | 2,790 | Common Stock |
| Nuvectis Pharma Inc | Ron Bentsur | Director, Chairman & CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 12.08 per share. | 21 Mar 2023 | 480 | 3,228,099 | - | 12.1 | 5,798 | Common Stock |
| Beyond Air Inc | Ron Bentsur | Director | 20 Mar 2023 | 2,300 | 144,736 (0%) | 0% | 6.5 | 14,904 | Common Stock | |
| Nuvectis Pharma Inc | Ron Bentsur | Director, Chairman & CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 10.85 per share. | 14 Mar 2023 | 1,680 | 3,227,139 | - | 10.9 | 18,228 | Common Stock |
| Nuvectis Pharma Inc | Ron Bentsur | Director, Chairman & CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 10.91 per share. | 14 Mar 2023 | 480 | 3,227,619 | - | 10.9 | 5,237 | Common Stock |
| Nuvectis Pharma Inc | Ron Bentsur | Director, Chairman & CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2023 | 210,000 | 3,225,459 | - | 0 | Common Stock | |
| Nuvectis Pharma Inc | Ron Bentsur | Director, Chairman & CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 7.45 per share. | 30 Nov 2022 | 150 | 3,015,459 | - | 7.5 | 1,118 | Common Stock |
| Nuvectis Pharma Inc | Ron Bentsur | Director, Chairman & CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 7.45 per share. | 25 Nov 2022 | 150 | 3,015,309 | - | 7.5 | 1,118 | Common Stock |
| Nuvectis Pharma Inc | Ron Bentsur | Director, Chairman & CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 7.40 per share. | 25 Nov 2022 | 150 | 3,015,159 | - | 7.4 | 1,110 | Common Stock |
| Nuvectis Pharma Inc | Ron Bentsur | Director, Chairman & CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 7.38 per share. | 25 Nov 2022 | 150 | 3,015,009 | - | 7.4 | 1,107 | Common Stock |
| Nuvectis Pharma Inc | Ron Bentsur | Director, Chairman & CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 7.23 per share. | 17 Nov 2022 | 500 | 3,014,859 | - | 7.2 | 3,615 | Common Stock |
| Nuvectis Pharma Inc | Ron Bentsur | Director, Chairman & CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 7.24 per share. | 17 Nov 2022 | 250 | 3,014,359 | - | 7.2 | 1,810 | Common Stock |
| Nuvectis Pharma Inc | Ron Bentsur | Director, Chairman & CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 7.07 per share. | 10 Nov 2022 | 1,000 | 3,014,109 | - | 7.1 | 7,070 | Common Stock |
| Nuvectis Pharma Inc | Ron Bentsur | Director, Chairman & CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 7.46 per share. | 28 Sep 2022 | 500 | 3,013,109 | - | 7.5 | 3,730 | Common Stock |
| Nuvectis Pharma Inc | Ron Bentsur | Director, Chairman & CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 7.23 per share. | 28 Sep 2022 | 500 | 3,012,609 | - | 7.2 | 3,615 | Common Stock |
| Nuvectis Pharma Inc | Ron Bentsur | Director, Chairman & CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 7.93 per share. | 23 Sep 2022 | 1,000 | 3,011,609 | - | 7.9 | 7,930 | Common Stock |
| Nuvectis Pharma Inc | Ron Bentsur | Director, Chairman & CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 7.69 per share. | 23 Sep 2022 | 500 | 3,012,109 | - | 7.7 | 3,845 | Common Stock |
| Nuvectis Pharma Inc | Ron Bentsur | Director, Chairman & CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 8.37 per share. | 01 Sep 2022 | 1,200 | 3,010,609 | - | 8.4 | 10,044 | Common Stock |
| Nuvectis Pharma Inc | Ron Bentsur | Director, Chairman & CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 8.11 per share. | 01 Sep 2022 | 500 | 3,009,409 | - | 8.1 | 4,055 | Common Stock |
| Nuvectis Pharma Inc | Ron Bentsur | Director, Chairman & CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 9.07 per share. | 23 Aug 2022 | 1,000 | 3,008,909 | - | 9.1 | 9,070 | Common Stock |
| Nuvectis Pharma Inc | Ron Bentsur | Director, Chairman & CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 9.00 per share. | 23 Aug 2022 | 500 | 3,007,909 | - | 9 | 4,500 | Common Stock |
| Nuvectis Pharma Inc | Ron Bentsur | Director, Chairman & CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 8.58 per share. | 18 Aug 2022 | 14,426 | 3,002,409 | - | 8.6 | 123,775 | Common Stock |
| Nuvectis Pharma Inc | Ron Bentsur | Director, Chairman & CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 8.99 per share. | 18 Aug 2022 | 5,000 | 3,007,409 | - | 9.0 | 44,950 | Common Stock |
| Nuvectis Pharma Inc | Ron Bentsur | Director, Chairman & CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 8.40 per share. | 11 Aug 2022 | 19,669 | 2,987,983 | - | 8.4 | 165,220 | Common Stock |
| Beyond Air Inc | Ron Bentsur | Director | 30 Jun 2022 | 40,000 | 142,436 (0%) | 0% | 6.5 | 261,104 | Common Stock | |
| Nuvectis Pharma Inc | Ron Bentsur | Director, Chairman & CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 11.62 per share. | 28 Jun 2022 | 3,700 | 2,968,314 | - | 11.6 | 42,994 | Common Stock |
| Nuvectis Pharma Inc | Ron Bentsur | Director, Chairman & CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 11.82 per share. | 28 Jun 2022 | 300 | 2,964,614 | - | 11.8 | 3,546 | Common Stock |
| Nuvectis Pharma Inc | Ron Bentsur | Director, Chairman & CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 12.18 per share. | 22 Jun 2022 | 400 | 2,964,314 | - | 12.2 | 4,872 | Common Stock |
| Nuvectis Pharma Inc | Ron Bentsur | Director, Chairman & CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 11.40 per share. | 22 Jun 2022 | 200 | 2,963,914 | - | 11.4 | 2,280 | Common Stock |
| Nuvectis Pharma Inc | Ron Bentsur | Director, Chairman & CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 13.10 per share. | 22 Jun 2022 | 100 | 2,963,714 | - | 13.1 | 1,310 | Common Stock |
| Nuvectis Pharma Inc | Ron Bentsur | Director, Chairman & CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 15.90 per share. | 26 May 2022 | 500 | 2,963,114 | - | 15.9 | 7,950 | Common Stock |
| Nuvectis Pharma Inc | Ron Bentsur | Director, Chairman & CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 15.74 per share. | 26 May 2022 | 500 | 2,963,614 | - | 15.7 | 7,870 | Common Stock |
| Nuvectis Pharma Inc | Ron Bentsur | Director, Chairman & CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 16.28 per share. | 19 May 2022 | 1,000 | 2,962,614 | - | 16.3 | 16,280 | Common Stock |
| Nuvectis Pharma Inc | Ron Bentsur | Director, Chairman & CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 18.95 per share. | 19 May 2022 | 200 | 2,961,614 | - | 19.0 | 3,790 | Common Stock |
| Nuvectis Pharma Inc | Ron Bentsur | Director, Chairman & CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 18.49 per share. | 17 May 2022 | 1,000 | 2,961,414 | - | 18.5 | 18,490 | Common Stock |
| Nuvectis Pharma Inc | Ron Bentsur | Director, Chairman & CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 20.60 per share. | 17 May 2022 | 700 | 2,960,414 | - | 20.6 | 14,420 | Common Stock |
| Nuvectis Pharma Inc | Ron Bentsur | Director, Chairman & CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 19.77 per share. | 17 May 2022 | 200 | 2,959,604 | - | 19.8 | 3,954 | Common Stock |
| Nuvectis Pharma Inc | Ron Bentsur | Director, Chairman & CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 20.83 per share. | 17 May 2022 | 110 | 2,959,714 | - | 20.8 | 2,291 | Common Stock |
| Nuvectis Pharma Inc | Ron Bentsur | Director, Chairman & CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 19.32 per share. | 13 May 2022 | 1,000 | 2,959,404 | - | 19.3 | 19,320 | Common Stock |
| Nuvectis Pharma Inc | Ron Bentsur | Director, Chairman & CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 18.10 per share. | 13 May 2022 | 700 | 2,958,404 | - | 18.1 | 12,670 | Common Stock |
| Nuvectis Pharma Inc | Ron Bentsur | Director, Chairman & CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 17.26 per share. | 12 May 2022 | 10,545 | 2,957,704 | - | 17.3 | 182,007 | Common Stock |
| Nuvectis Pharma Inc | Ron Bentsur | Director, Chairman & CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 14.88 per share. | 12 May 2022 | 1,100 | 2,946,559 | - | 14.9 | 16,368 | Common Stock |
| Nuvectis Pharma Inc | Ron Bentsur | Director, Chairman & CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 16.12 per share. | 12 May 2022 | 600 | 2,947,159 | - | 16.1 | 9,672 | Common Stock |
| Nuvectis Pharma Inc | Ron Bentsur | Director, Chairman & CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2022 | 120,000 | 2,945,459 | - | 0 | Common Stock | |
| Nuvectis Pharma Inc | Ron Bentsur | Director, Chairman & CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 7.05 per share. | 28 Mar 2022 | 4,000 | 2,825,459 | - | 7.1 | 28,200 | Common Stock, par value $0.00001 |
| Nuvectis Pharma Inc | Ron Bentsur | Director, Chairman & CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 7.63 per share. | 17 Mar 2022 | 7,000 | 2,821,459 | - | 7.6 | 53,410 | Common Stock, par value $0.00001 |
| Beyond Air Inc | Ron Bentsur | Director | 03 Mar 2022 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | ||
| Nuvectis Pharma Inc | Ron Bentsur | Director, Chairman & CEO | Purchase of securities on an exchange or from another person at price $ 5.88 per share. | 14 Feb 2022 | 8,000 | 2,814,459 | - | 5.9 | 47,040 | Common Stock, par value $0.00001 |
| Nuvectis Pharma Inc | Ron Bentsur | Director, Chairman & CEO | Purchase of securities on an exchange or from another person at price $ 6.34 per share. | 10 Feb 2022 | 8,500 | 2,806,459 | - | 6.3 | 53,890 | Common Stock, par value $0.00001 |
| Nuvectis Pharma Inc | Ron Bentsur | Director, Chairman & CEO | Purchase of securities on an exchange or from another person at price $ 5.00 per share. | 04 Feb 2022 | 200,000 | 2,765,459 | - | 5 | 1,000,000 | Common Stock, par value $0.00001 |
| Nuvectis Pharma Inc | Ron Bentsur | Director, Chairman & CEO | Purchase of securities on an exchange or from another person at price $ 3.93 per share. | 04 Feb 2022 | 14,000 | 2,791,959 | - | 3.9 | 55,020 | Common Stock, par value $0.00001 |
| Nuvectis Pharma Inc | Ron Bentsur | Director, Chairman & CEO | Purchase of securities on an exchange or from another person at price $ 3.89 per share. | 04 Feb 2022 | 12,500 | 2,777,959 | - | 3.9 | 48,625 | Common Stock, par value $0.00001 |
| Nuvectis Pharma Inc | Ron Bentsur | Director, Chairman & CEO | Purchase of securities on an exchange or from another person at price $ 8.25 per share. | 04 Feb 2022 | 6,000 | 2,797,959 | - | 8.3 | 49,500 | Common Stock, par value $0.00001 |
| Beyond Air Inc | Ron Bentsur | Director | 24 Nov 2021 | 31,000 | 188,900 (1%) | 0% | 13.4 | 416,640 | Common Stock | |
| Beyond Air Inc | Ron Bentsur | Director | 24 Nov 2021 | 6,464 | 182,436 (1%) | 0% | 14.0 | 90,431 | Common Stock | |
| Beyond Air Inc | Ron Bentsur | Director | 22 Nov 2021 | 50,000 | 232,436 (1%) | 0% | 3.7 | 183,000 | Common Stock | |
| Beyond Air Inc | Ron Bentsur | Director | 22 Nov 2021 | 50,000 | 0 | - | - | Warrants (right to buy) | ||
| Beyond Air Inc | Ron Bentsur | Director | 22 Nov 2021 | 12,536 | 219,900 (1%) | 0% | 14.6 | 182,988 | Common Stock |